{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:26:05Z","timestamp":1787286365707,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.7759\/cureus.114898","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:13:26Z","timestamp":1787285606000},"source":"Crossref","is-referenced-by-count":0,"title":["Antimicrobial Susceptibility Pattern of Ceftriaxone-Sulbactam-EDTA Against Multidrug-Resistant Gram-Negative Bacilli From ICU Clinical Isolates"],"prefix":"10.7759","author":[{"given":"Vaishnavi G","family":"Chavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyajeet","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022, 399:629-55. 10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"key":"ref2","unstructured":"World Health Organization. WHO bacterial priority pathogens. (2024). Accessed: July 11, 2026: https:\/\/www.who.int\/publications\/i\/item\/9789240093461."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos AP","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al.. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012, 18:268-81. 10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-lactams and \u03b2-lactamase inhibitors: an overview","volume":"6","author":"Bush K","year":"2016","unstructured":"Bush K, Bradford PA. \u03b2-lactams and \u03b2-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med. 2016, 6:a025247. 10.1101\/cshperspect.a025247","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2015\/14129.6840","article-title":"A combination strategy of ceftriaxone, sulbactam and disodium edetate for the treatment of multi-drug resistant (MDR) septicaemia: a retrospective, observational study in Indian Tertiary Care Hospital","volume":"9","author":"Patil UN","year":"2015","unstructured":"Patil UN, Jambulingappa KL. A combination strategy of ceftriaxone, sulbactam and disodium edetate for the treatment of multi-drug resistant (MDR) septicaemia: a retrospective, observational study in Indian Tertiary Care Hospital. J Clin Diagn Res. 2015, 9:FC29-32. 10.7860\/JCDR\/2015\/14129.6840","journal-title":"J Clin Diagn Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-23573","article-title":"A comparative in vitro sensitivity study of \"Ceftriaxone-Sulbactam-EDTA\" and various antibiotics against Gram-negative bacterial isolates from intensive care unit","volume":"24","author":"Singh S","year":"2020","unstructured":"Singh S, Sahu C, Patel SS, Singh A, Yaduvanshi N. A comparative in vitro sensitivity study of \"Ceftriaxone-Sulbactam-EDTA\" and various antibiotics against Gram-negative bacterial isolates from intensive care unit. Indian J Crit Care Med. 2020, 24:1213-7. 10.5005\/jp-journals-10071-23573","journal-title":"Indian J Crit Care Med"},{"key":"ref7","unstructured":"Fixed dose combinations approved by DCG(I) since 1961 to 31st December 2019. (2019). Accessed. July 11, 2026: https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadApprovalMarketingFDC\/FIXED%20DOSE%20COMBINATIONS%20A...."},{"key":"ref8","article-title":"Performance standards for antimicrobial susceptibility testing: CLSI supplement M100, 34th ed.","author":"Clinical and Laboratory Standards Institute","year":"2024","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: CLSI supplement M100, 34th ed.. Clinical and Laboratory Standards Institute, Wayne, PA; 2024."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.20546\/ijcmas.2017.611.191","article-title":"Detection of ESBLs, MBLs and AmpCs in Gram-negative clinical isolates","volume":"6","author":"Fatima A","year":"2017","unstructured":"Fatima A, Gandham P, Nandeshwar AJ. Detection of ESBLs, MBLs and AmpCs in Gram-negative clinical isolates. Int J Curr Microbiol App Sci. 2017, 6:1594-1604. 10.20546\/ijcmas.2017.611.191","journal-title":"Int J Curr Microbiol App Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20181043","article-title":"The incidence of AmpC \u03b2-lactamases producing Klebsiella pneumoniae subspecies pneumoniae","volume":"6","author":"Singh P","year":"2018","unstructured":"Singh P. The incidence of AmpC \u03b2-lactamases producing Klebsiella pneumoniae subspecies pneumoniae. Int J Res Med Sci. 2018, 6:1169-73. 10.18203\/2320-6012.ijrms20181043","journal-title":"Int J Res Med Sci"},{"key":"ref11","article-title":"Comparative efficacy of antibiotics in biofilms eradication formed by ESBL and non-ESBL producing microorganisms","volume":"4","author":"Chaudhary M","year":"2012","unstructured":"Chaudhary M, Payasi A. Comparative efficacy of antibiotics in biofilms eradication formed by ESBL and non-ESBL producing microorganisms. Int J Drug Dev Res. 2012, 4:138-47.","journal-title":"Int J Drug Dev Res"},{"key":"ref12","article-title":"Ceftriaxone-sulbactam-EDTA susceptibility profile of multi-drug resistant Gram-negative bacterial isolates: experience from a tertiary care teaching hospital in Rishikesh, Uttarakhand","volume":"11","author":"Paul M","year":"2020","unstructured":"Paul M, Bhatia M, Raj AK, Mangla A, Omar BJ, Gupta P. Ceftriaxone-sulbactam-EDTA susceptibility profile of multi-drug resistant Gram-negative bacterial isolates: experience from a tertiary care teaching hospital in Rishikesh, Uttarakhand. J Nat Sci Biol Med. 2020, 11:189-93.","journal-title":"J Nat Sci Biol Med"},{"key":"ref13","article-title":"Nosocomial infections","author":"Sikora A","year":"2026","unstructured":"Sikora A, Zahra F. Nosocomial infections. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-023-00636-5","article-title":"Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study","volume":"22","author":"Maina JW","year":"2023","unstructured":"Maina JW, Onyambu FG, Kibet PS, Musyoki AM. Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study. Ann Clin Microbiol Antimicrob. 2023, 22:85. 10.1186\/s12941-023-00636-5","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-12315-1","article-title":"Prevalence and antimicrobial susceptibility of multi drug-resistant bacteria isolates in adult intensive care units: a six-year retrospective study from a tertiary hospital in Mogadishu, Somalia","volume":"26","author":"\u00c7elik AK","year":"2025","unstructured":"\u00c7elik AK, T\u00fcrkan M, Ali TA, Isse SA, Mohmud FA, Hussein LA, Ali AM. Prevalence and antimicrobial susceptibility of multi drug-resistant bacteria isolates in adult intensive care units: a six-year retrospective study from a tertiary hospital in Mogadishu, Somalia. BMC Infect Dis. 2025, 26:137. 10.1186\/s12879-025-12315-1","journal-title":"BMC Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.681731","article-title":"Different infection profiles and antimicrobial resistance patterns between burn ICU and common wards","volume":"11","author":"Gong Y","year":"2021","unstructured":"Gong Y, Peng Y, Luo X, et al.. Different infection profiles and antimicrobial resistance patterns between burn ICU and common wards. Front Cell Infect Microbiol. 2021, 11:681731. 10.3389\/fcimb.2021.681731","journal-title":"Front Cell Infect Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00074","article-title":"Treatment of infections due to MDR Gram-negative bacteria","volume":"6","author":"Bassetti M","year":"2019","unstructured":"Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of infections due to MDR Gram-negative bacteria. Front Med (Lausanne). 2019, 6:74. 10.3389\/fmed.2019.00074","journal-title":"Front Med (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy210.1204","article-title":"1373. Activity of ceftriaxone-sulbactam-EDTA against multi-drug-resistant A. baumannii, P. aeruginosa and Enterobacteriaceae Isolates (WHO Critical Priority Pathogens) collected from various hospitals in India","volume":"5","author":"Girotra R","year":"2018","unstructured":"Girotra R, Pyasi A, Chaudhary M, Patil NS, Mir MA, Chaudhary S, Mandale P. 1373. Activity of ceftriaxone-sulbactam-EDTA against multi-drug-resistant A. baumannii, P. aeruginosa and Enterobacteriaceae Isolates (WHO Critical Priority Pathogens) collected from various hospitals in India. Open Forum Infect Dis. 2018, 5:S421. 10.1093\/ofid\/ofy210.1204","journal-title":"Open Forum Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/509828-antimicrobial-susceptibility-pattern-of-ceftriaxone-sulbactam-edta-against-multidrug-resistant-gram-negative-bacilli-from-icu-clinical-isolates","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:13:27Z","timestamp":1787285607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/509828-antimicrobial-susceptibility-pattern-of-ceftriaxone-sulbactam-edta-against-multidrug-resistant-gram-negative-bacilli-from-icu-clinical-isolates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.114898","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}